A male child presented on the first day of life with metabolic acidosis with elerated blood lactate 115 mM), pyruvate (0.4 mM I, and free fatty acid (1.3 m V ) levels and a blood pH of 7.16. The reverity of the acidosis was diminished by intravenous administration of glucose in large doses and by bicarbonate. On two occasions, when the acidosis was particularly se\ere. peritoneal dialvsis using an acetate buffer was required. Restriction of the dietar! intake of saturated fatty acids or treatment with nicotinic acid also appeared to diminish the se~erity of acidosis. Uo improvement was achieted by the administration of thiamine or biotin. Tissues taken at postmortem showed normal activity of gluconeogenic enzymes and pyruvate dehydrogenase. The activity of pvrutate dehydrogenase in tissue homogenates preincubated with ATP was reduced by 6&7S% both in liver of the patient and of the controls because of the inactitation of the enzyme by pyruvate dehydrogenase kinase. Addition of C a + + and M g + + to the inactivated enzyme caused a prompt return of the activity to normal in controls but not in the patient. This defect, which was apparent in muscle and liter but not in brain, we attribute to a markedly reduced acthity of pyrurate dehydrogenase phosphatase in the patient.
Chronic congenital lactic acidosis of infancy is a disease characterized hy a persistent elevation of blood pyruvate and lactate (9, 15, 16, 21) . In three patients with chronic congenital lactic acidosis, markedly reduced activity of pyruvate dehydrogenase (EC. 1.2.4.1) was reported. In two of these, the defect was localized in the py ruvate decarboxylase (EC. 4. I. I . I) component of the enzyme complex (8, 14) and in the third patient in the dehydrolipoyl transacetylase (EC. 2.3.1.12) or the dihydrolipoyl dehydrogenase (EC. 1.6.4.3) component (9) .
In this communication, we report a patient with chronic congenital lactic acidosis in whom biochemical investigations on tissue obtained at postmortem revealed a defect in the phosphorylation-dephosphorylation mechanisms controling the overall activity of the pyruvate dehydrogenase complex in the liver and muscle. The postulated defect is correlated with the clinical manifestations of the disease during the life of the patient.
noted from the first day of life. At birth in our patient the Apgar score was 8 at 1 min, hut acidosis developed during the first day of life and the patient was transrerred to The Hospital for Sick Children.
He was 3 well developed newborn with severe tachypnoea of the Kussmaul type. poor peripheral perfusion, hypotonicity, ond diminished consciousness. He did not have evidence of cardiopulmonary disease nor hepatomegaly. His biochemical data on admission are shown in Table 1 and indicated a metabolic acidosis associated with elevated levels of blood lactate (15 m M N < 2 mM), pyruvate (0.4 m M N < 0.2 mM), @-hydroxybutyrate (1.8 m M N < 0.5 mM), acetoacetate (0.36 m M N < 0.15 mM), and alanine (1.0 m M N < 0.5). The plasma free fatty acid level was elevated; the plasma glucose level was normal. Amino acid analysis of plasma and urine showed no abnormalities other than an elevated alanine level. Gas-liquid chromatography showed no abnormal organic acids to be oresent in the urine.
L
Therapy was commenced with an intravenous infusion of sodium bicarbonate (4-5 mEq/kg/hr) and glucose (4 mg/kg/min). The clinical and biochemical parameters did not alter appreciably until the 6th day of life when the rate of glucose infusion was increased to 12 mg/kg/min. Within 36 hr the plasma ketones had markedly decreased and the ketonuria had disappeared. The blood lactate had fallen from the previous range of 15-20 mM to 6 m M . The rate of infusion of both glucose and sodium bicarbonate was reduced. Commercial formula feeds ( S M A ) were commenced. The infant improved clinically and behaved normally.
During the stable periods of the infant's life, the basal blood lactate level remained in the range of 4-7 m M ( N < 2 m M ) and ketonuria was absent. At no time was hypoglycemia apparent. However, intermittent exacerbation of both lactic and ketoacidosis occurred at unpredictable and varying intervals. every 4 12 days. lasting for 3-5 days. When the blood lactate level rose to 9-15 mM. oral bicarbonate therapy (20-25 mEq/kg/24 hr) usually controlled the acidosis. At other times, when the blood lactate level rose to 15-20 m M and the B-hydroxybutyrate to 2.5-3.5 m M , more vigorous therapy was required. It was the episodic nature of this infant's clinical course that made the assessment of the clinical and biochemical effects of therapeutic measures difficult. At the age of 3-4 months, neurologic damage became increasingly evident with intermittent lethargy, irritability, and intermittent generalized seizure activity. The infant did not respond appropriately to stimuli. Death occurred at the age of 6 months.
METHODS CASE REPORT
Lactate (2), pyruvate (3). 8-hydroxybutyrate (4), acetoacetate The male patient was born in February 1974 to nonconsanguine-(5), citrate (6) . and a-ketoglutarate (7) were measured in whole ous Caucasian parents after an uneventful pregnancy at full term blood samples extracted I:1 with 0.6 N perchloric acid by enzyme with a birth weight or 3.2 kg. The mother was 27 years old, gravida spectrophotometric methods. Free fatty acids were measured in 3, para 3. A 7-year-old brother was nwmal. A sister had died at the plasma by the method of Laurell and Tibbling (20) . age of 6 weeks with a chronic metabolic acidosis that had been Liver. brain, and muscle tissue was obtained 1 hr after death at 936 ROBINSON AND SHERWOOD and centrifuged at 600 x R for 10 min to remove cell debris.
Glucose-6-phosphatase was measured by the method of Swanson (30) . fructose-1.6-diphosphatase by the method of Pontremoli (24) . phosphoenolpyruvate carboxykinase by the method of Roobol and
Alleyne (25) . and pyruvate carboxylase by the method of Crabtree et a/. (12) . For the determination of pyruvate dehydrogenase activity the method of Taylor et a/. was used (3 1 ). The assay of whole tissue pyruvate dehydroyenase activity was carried out using 300 4 0 0 mg freshly thawed tissue homogenized in 10 volumes ice-cold buffer containing 10 m M potassium phosphate. I mM EDTA. 1 mM dithiothreitol, 1 % fatty acid free bovine serum albumin, pH 7.4. Aliquots of 0.1 ml were then added to the main chamber of 10-ml Erlenmeyer flasks containing 0.8 ml assay buffer (I I m M potassium phosphate, 1.1 m M EDTA, 2.8 mM MgCI,, 1.6% bovine serum albumin (fatty acid free). 1.2 niM dithiothreitol. 0.3 m M pyruvate labeled with 0.12 pCi [l-'4C]pyruvate/ml at pH 7.4 and 37"). The flasks were fitted with plastic inserts holding strips of filter paper (I x 3 c m ) saturated with 0.2 ml Hy~imine and closed with a rubber stopper. The reaction was stopped after a given time interval by injecting 0.8 ml 0.08 M citric acid. 0.04 M N a , H P 0 4 buffer (pH 3.0). After 30 rnin of further incubation the filter strips were removed with forceps and placed in 10 ml toluene-ethanol (9:1, V / V ) scintillation fluid and the 14C activity measured in a Beckman liquid scintillation spectrometer.
Preincubations were carried out by warming nliquots of the homogenate to 37' and adding various effectors (ATP. Ca ++, and Mg") in concentrations and for the times given in the text. Aliquots of 0.1 ml were then transferred to the assay system above. The time dependence of this assay system is shown in Figure 1 using control tissue from liver and brain with and without preincubation of the homogenate with ATP. Linearity is evident up to a period of 2 min under the conditions used. Then nicotinic acid therapy was discontinued and corn oil was added to the diet of skim milk and glucose. Six grams corn oil per day added a further 15 cal/kg/24 hr. On this diet, the basal lactate level was in the range of 7-1 I mM. However. several moderate exacerbations of acidosis occurred with blood lactate levels up to 15 m M . At these times, reinstitution of intravenous glucose and1 bicarbonate resulted in a fall in the degree of acidosis. However, on two occasions, the blood lactate rose to the range or 18-25 mM whereupon peritoneal dialysis was instituted with an acetate bufferm solution (Plasmalyte 56). This rapidly controlled the acidosis and the blood lactate levels fell to 10-12 m M over the 48-hr duration, of each dialysis. When dialysis was discontinued, glucose and bicarbonate therapy was reintroduced and during the following 4-5' days. the blood lactate levels fell to the range of 3-4 m M .
On three occasions when the modified diet of skim milk. glucose. and corn oil was replaced by S M A oral feeds. a moderate to severe exacerbation of acidosis occurred within 12-24 hr.
Neither thiamine hydrochloride (20 mg im for 5 days) nor biotin (5 mg iv over I2 hr) produced any change in the basal blood lactate concentration. The activities of glucose-6-phosphatase. phosphoenolpyruvnte carboxykinase. pyruvate carboxyiase, and pyruvate dehydrogeni~se in the liver honiogenate were all within the normal range. whereas the activity of fructose-1.6-diphosphatase was elevated Table 2 ).
Since the enzyme activities measured indicated neither a block in gluconeogenesis nor a block in pyruvate oxidation, the possibil-( ity of a defect in the control of pyruvate decarhoxylation was investigated. Using tissue homogenates of the patient and controls the pyruvate dehydrogenase activity was measured before and after preincubation with ATP. which is known to inactivate pyruvate dehydrogenase by increasing the activity of the controling enzyme, pyruvate dehydrogenase kinase (13. 14). The results of such an experiment are shown in Figure 2 . A T P appeared to have the predictable effect in the case of both the patient and the control. Preincubation of liver homogenate for 2 niin with 0.2 niM ATP resulted in marked reduction of pyruvnte dehydrogenase activity in both the control and the patient tissue. respectively. After this. the reactivation of pyruvnte dehydropenase was investigated. It is known that C a + + activates pyruvate dehydrogenase phosphatase. an enxyme which converts inactive phosphopyruvate dehydrogenase to its dephosphorylated active form ( 1 3, 33). I t can be seen in the ri~hr-hand parlel of Figure 2 that addition of
RESULTS

BIOCHEMICAL INVESTIGATIONS D U R I N G PATIENT'S LIFE
Based on the repeatedly observed good therapeutic response to intravenous glucose, a low fat, hish carbohydrate diet was introduced which supplied protein (2.5 g/kp/24 hr) in skim milk with added glucose to provide a total of 80 cal/kg/24 hr. This was fed at 2-hour intervals for 20 days. During that time the basal lactate levels remained in the range of 7 9 m M . Three moderate exacerbations of the acidosis occurred with lactate levels of the order of 9-12 mM.
Then, while continuing this low fat, carbohydrate diet. nicotinic acid was administered orally in increasing doses up to 300 (32) . and the "CO, collected after acidification of the incubation medium to pH 3.0. This experiment was repeated with homogenates which had been preincubated with 0.2 mM ATP for 3 min.
PYRUVATE DEHYDROGENASE PHOSPHATASE AND LACTIC ACIDOSIS
937 m M C a + + t o the control liver homogenate resulted in rapid :activation of pyruvute dehydrogenase and within 6 min activity a s restored almost t o that level before in;lctivation. However. the ddition of 2 m M C a + * t o the patient's liver homogenate. as hown in the left-hand pat~el of Figure I . resulted in only minimal :activation.
In Table 3 results of similar studies a r e shown with homogenates f liver and also with muscle and brain homogenates of both the ~atient and controls.
In order to determine whether this defect was localized in liver. ~ornogrnates o r liver, muscle. and brain were incubated under five ets of conditions and the activity of pyruvute dehydrogenose was neasured (Table 3) . A T P reduced the activity of pyruvate lehydrogenase in all three tissues in both the patient and in the ontrols. T h e degree of inactivation was somewhat variable. .specially in muscle. T h e extent of inactivation found in the tissues jfthe patient was within the range of controls in the liver, although >lightly lower in niuscle and brain. When Ca-' (10 m M ) and Mg" (10 m M ) were added to reactivate the pyruvate dehydroyenase, activity in the liver of controls was restored in 5 rnin from of the original activity to 83V'. However, with the patient's liver homogenate the degree of reactivation was from 39.9? t o 44. I "+.
indicating a markedly reduced ability of the patient to r e a c t i v~~t e the enzyme. A similar effect was seen in n~u s c l e . Although reactivation in this case was variable in controls. it was minimal in the tissues of the patient. An alternative method t o adding C a tand M g + + of stimulating conversion of inactive lo the active form of this enzyme is by the removal of A T P through the hexokinase reaction. Addition of glucose and hexokinase after inactivation with A T P gave consistent reactivation in controls. but only a very small reactivation in the patient. Addition of C a + + and Mg" t o homogenates in the absence of A T P had little effect on the activity of pyruvate dehydrogenase in any of the tissues. In brain. however, although one only control specimen was available. inactivation and reactivation occurred both in patient and control t o a similar extent. Pyruvate dehydrogenase activity was determined in tissue homogenates as described in Reference 31 after the following preincubations; (a) no additions; (b) plus 0.2 mM ATP for 3 min; (c) plus 0.2 mM ATP for 3 rnin followed by 10 mM C a + + and 10 mM Mg++; (d) plus 0.2 mM ATP for 3 rnin followed by 5 mM glucose and 2 U hexokinase for 3 min; (e) plus I0 mM Mg++ and 10 mM C a + + for 3 min.
ROBINSON AND SHERWOOD DISCUSSION CLINICAL AND CHEMICAL STUDIES DURING LIFE
The clinical history. the course of the disease. and the laboratory data obtained during life in this patient provide some very pertinent clues when one considers the etiology of chronic congenital lactic acidosis. That the disease is familial is shown in this case by the fact that a female sib of the patient died at 6 weeks of age with a severe lactic acidosis. Both lactate and pyruvate were elevated, which indicated that pyruvate was not being metabolized and although the lactate t o pyruvate ratio was abnorn~ally high, there was no apparent hypoxia. The absence of hypoglycemia at any point during the course of the patient's disease suggested that the lactic acidosis was not due to a primary block in the gluconeogenic pathway such as is seen in pyruvate carboxylase deficiency ( l o ) , fructose-1,6-diphosphatase deficiency (I). or type I glycogen storage disease (glucose-6-phosphatase deficiency) (26) . The onset from birth, the severity of the acidosis, and the absence of a raised plasma a-ketoglutarate or citrate level made the possibility of Leigh's disease unlikely (17, 36) . The absence of abnormal urinary organic acids ruled out the possibility that the lactic acidosis was secondary to a block in propionate or methylmalonate metabolism.
The Finding of elevated plasma free Fatty acid levels in this patient raised the possibility of a defect in fat metabolism, but this was deemed unlikely, at least in liver. because of the presence of ketone bodies in the plasma which indicated that fatty acids were being oxidized. Nevertheless, it was observed that a high dietary fat intake, especially of saturated fatty acids. made the acidosis worse, whereas a high carbohydrate intake seemed to correct the acidosis. Unsaturated fats appeared to be tolerated better than saturated fats. Reduction of circulating free fatty acid levels by nicotinic acid therapy appeared to have a beneficial effect though the lactic acidosis was still evident. Summarizing this information, we felt that although a plentiful dietary supply of saturated fatty acids had an adverse effect on the acidosis, a primary defect in the catabolism of fat was unlikely to be the cause of the lactic acidosis.
POSTMORTEM STUDIES
The finding of normal activities of the key gluconeogenic enzymes in the liver of the patient confirmed our suspicion that a primary block did not exist in the gluconeogenic pathway. The initial finding of adequate pyruvate dehydrogenase activity was at first disconcerting since a distinct possibility existed of a defect in this enzyme, such as in the case described by Blass er a/. (8) . However, since pyruvate dehydrogenase is a multienryme complex, the overall activity of which is closely controlled by a phosphorylation-dephosphorylation mechanism (22. 23). we felt that a defect in this control system might be a cause of chronic lactic acidosis.
Phosphorylation (and inactivation) of pyruvate dehydrogenase is catalyzed by a specific kinase, which requires magnesium ions and ATP. and which may be subject to inhibition by high concentrations of pyruvate or A D P (Fig. 3) . Conversion of pyruvate dehydrogenase phosphate back to the active pyruvate dehydrogenase is catalyzed by a specific phosphatase requiring the divalent metal ions, M g C + and C a + + (13, 33) . This regulatory system has been demonstrated to be active in muscle. brain, liver. kidney. and adipose tissue (13, 22, 32, 33. 35 ). but a theory or concept as to how the system operates to modulate pyruvd dehydrogenase activity in viva has only recently been proposed (3 34) .
In order to explain the change from the active to the inacti', form of pyruvate dehydrogenase a s a result of the transition from1 fed to a fasted state, it has been proposed that on fasting, free fat acid levels increase. thus leading to increased tissue levels of lor chain acyl-CoA thioesters. which inhibit the mitochrondrial ad nine nucleotide translocase system (23, 28) and the citrate-tran porting system (1 1, 18) . whereupon the intramitochondrial co centrations of both citrate and A T P rise. This has two effects: firs both these compounds effectively chelate C a + + and M g t + an prevent them from activating the phosphatase. Second. tv elevated level of A T P ensures that the kinase brings a b o~ inactivation of the pyruvate dehydrogenase coniplex. When fatt acyl-CoA levels fall, the intramitochondrial A T P and citrate levei fall, C a + + and M g f + are released, and the phosphatase restore the inactive pyruvate dehydrogenase to the active form again.
We have demonstrated in the patient that pyruvate dehydrogen ase phosphatase is defective in muscle and liver. having a estimated activity between 0 and 10% of normal. The fact tha some activity of the phosphatase exists explains why the pyruvat dehydrogenase isolated from postmortem tissues appeared to bc almost fully activated. Since postmortem A T P levels in all tissue fall rapidly to extremely low levels. inactivity of pyruvate dehydro genase kinase would result. The low activity of the phosphatase i~ this patient would them be able to dephosphorylate the enzyme anc restore full activity. However, "it1 ~livo". one would expect tht predominance or the kinase and the deficiency of the phosphatasc to keep the pyruvate dehydrogenase complex in the inactive form Resulting from this inability t o fully oxidize the available pyruvatt would be an elevation of pyruvate and lactic levels resulting ir chrontc lactic acidosis. Any circumstance leading to elevation ol cissue fatty acyl-CoA esters would make the pyruvate dehydrogenase enzyme complex more inactive, a situation that concurs witd our observations that the lactic acidosis was exacerbated by dietary fatty acids and relieved by reduction of circulating fatty acids and use of nicotinic acid therapy.
There are two important clinical points arising from consideration of the biochemical aspects of lactic acidosis. It has been reported in two cases of congenital lactic acidosis that transfusion of patient with citrated blood caused a severe bout of acidosis (19. 27) . Consideration of the effect of citrate on pyruvate dehydrogenase phosphatase activity dictates that any activity in this enzyme would be drastically reduced by removing the activators C a t + and M g t + . If this enzyme is already defective in activity, citrate would have the effect of putting the pyruvate dehydrogenase con~plex completely in the inactive form. Also. acetate has been shown in vitro to activate the enzyme by inhibitins the kinase (31) . which might explain why peritoneal dialysis against acetate buffer in the patient was successful in alleviating the acidosis.
